Immuno Oncology Therapy Market In-depth Research covering sales outlook, demand forecast & up-to-date key trends
Immuno Oncology Therapy Market In-depth Research covering sales outlook, demand forecast & up-to-date key trends
The Immuno Oncology Therapy Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Immuno Oncology Therapy market is expected to grow at a CAGR of 4.7% during the forecast period.
The global Immuno Oncology Therapy market is estimated to be about 1307.0 million US dollars in 2020.
The global Immuno Oncology Therapy market is estimated to reach 1568.7 million USD by 2026.
The global Immuno Oncology Therapy market is segmented by company, region (country), type and application. Participants, stakeholders, and other readers in the global Immuno Oncology Therapy market will be able to gain an advantage as they use reports as a powerful resource.
Immuno Oncology Therapy markets by category
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Immuno Oncology Therapy Market by Application (Percentage of Demand)
Hospitals
Ambulatory Surgical Center
Others
Who are the leading companies in Immuno Oncology Therapy
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
BioNTech SE
Allogene Therapeutics
IMAB-I-Mab Biopharma Co., Ltd.
Arcus Biosciences
Gritstone Oncology
Autolus Therapeutics
Rubius Therapeutics
Immuno Oncology Therapy markets by region:
In North America
In Latin America
Europe
The Asia-pacific
Middle East and Africa (MEA)
What are the main countries covered
The United States
Canada
Germany
France
UK
Italy
Russia
China
Japan
Korea
Southeast Asia
India
Australia
Brazil
Mexico
Argentina
Chile
Colombia
Egypt
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Which is the most profitable market
Among regions, North America/Europe/Asia Pacific accounted for the largest share of global personalized beauty equipment as rising consumer incomes led to increased spending at Immuno Oncology Therapy.
What methodology did you follow in your research
This study was conducted by our expert analysts through a combination of primary and secondary studies. The methodology we follow includes a demand-side assessment of the market and triangulation of this through supply-side analysis. The methodology is based on the use of standard market structures, methods, and definitions.
Who were the primary study respondents
We talk to stakeholders across the spectrum. Including C-level executives, distributors, product manufacturers, industry experts, etc.
What are the sources of secondary research
We conduct extensive secondary studies using proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations and research papers.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Market Size Units
1.8 Review Cycle
2 Global Market Overview
2.1 Global Immuno Oncology Therapy Revenue and Growth Forecast 2014-2026
2.2 Global Immuno Oncology Therapy Market Size and Growth Forecast 2014-2026
2.3 Global Immuno Oncology Therapy Revenue by Region 2014-2026
2.4 Immuno Oncology Therapy Market Share by Major Regions 2014-2021
2.5 Immuno Oncology Therapy Gross Margin in Different Region 2014-2021
2.6 Global Immuno Oncology Therapy Market History Price and Forecast 2014-2026
2.7 Global Immuno Oncology Therapy Sales Market Share by Top Companies 2014-2021
3 Global Immuno Oncology Therapy Market by Type
3.1 Global Immuno Oncology Therapy Revenue and Growth Rate Segment by Types from 2014-2021
3.2 Global Immuno Oncology Therapy Market Size and Growth Rate Segment by Product Types from 2014-2021
3.3 Global Immuno Oncology Therapy Price Segment by Types from 2014-2021
3.4 Brief Introduction of Different Types
3.4.1 Monoclonal Antibodies
3.4.2 Immune Checkpoint Inhibitors
3.4.3 Immune System Modulators
3.4.4 Cancer Vaccines
4 Global Immuno Oncology Therapy Market by Application
4.1 Global Immuno Oncology Therapy Revenue and Growth Rate Segment by Applications from 2014-2021
4.2 Global Immuno Oncology Therapy Market Size and Growth Rate Segment by Product Applications from 2014-2021
4.3 Brief Introduction of Different Applications
4.3.1 Hospitals
4.3.2 Ambulatory Surgical Center
4.3.3 Others
5 North America Immuno Oncology Therapy Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
5.1 North America Immuno Oncology Therapy Value ($) from 2014-2021
5.2 North America Immuno Oncology Therapy Market Size from 2014-2021
5.3 North America Immuno Oncology Therapy Price Change from 2014-2021
5.4 North America Immuno Oncology Therapy Import and Export from 2014-2021
5.5 North America Immuno Oncology Therapy Market Value ($) and Growth (%) by Type from 2014-2021
5.6 North America Immuno Oncology Therapy Market Value ($) and Growth (%) by Application from 2014-2021
5.7 North America Immuno Oncology Therapy Market Value ($) and Growth (%) by Countries from 2014-2021
5.7.1 The United States
5.7.2 Canada
5.8 Top North America Immuno Oncology Therapy Participants Value ($) and Market Share (%) in 2020
6 Europe Immuno Oncology Therapy Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
6.1 Europe Immuno Oncology Therapy Value ($) from 2014-2021
6.2 Europe Immuno Oncology Therapy Market Size from 2014-2021
6.3 Europe Immuno Oncology Therapy Price Change from 2014-2021
6.4 Europe Immuno Oncology Therapy Import and Export from 2014-2021
6.5 Europe Immuno Oncology Therapy Market Value ($) and Growth (%) by Type from 2014-2021
6.6 Europe Immuno Oncology Therapy Market Value ($) and Growth (%) by Application from 2014-2021
6.7 Europe Immuno Oncology Therapy Market Value ($) and Growth (%) by Countries from 2014-2021
6.7.1 Germany
6.7.2 France
6.7.3 UK
6.7.4 Italy
6.7.5 Russia
…
6.8 Top Europe Immuno Oncology Therapy Participants Value ($) and Market Share (%) in 2020
7 Asia-Pacific Immuno Oncology Therapy Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
7.1 Asia-Pacific Immuno Oncology Therapy Value ($) from 2014-2021
7.2 Asia-Pacific Immuno Oncology Therapy Market Size from 2014-2021
7.3 Asia-Pacific Immuno Oncology Therapy Price Change from 2014-2021
7.4 Asia-Pacific Immuno Oncology Therapy Import and Export from 2014-2021
7.5 Asia-Pacific Immuno Oncology Therapy Market Value ($) and Growth (%) by Type from 2014-2021
7.6 Asia-Pacific Immuno Oncology Therapy Market Value ($) and Growth (%) by Application from 2014-2021
7.7 Asia-Pacific Immuno Oncology Therapy Market Value ($) and Growth (%) by Countries from 2014-2021
7.7.1 China
7.7.2 Japan
7.7.3 Korea
7.7.4 Southeast Asia
7.7.5 India
7.7.6 Australia
…
7.8 Top Asia-Pacific Immuno Oncology Therapy Participants Value ($) and Market Share (%) in 2020
8 Latin America Immuno Oncology Therapy Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
8.1 Latin America Immuno Oncology Therapy Value ($) from 2014-2021
8.2 Latin America Immuno Oncology Therapy Market Size from 2014-2021
8.3 Latin America Immuno Oncology Therapy Price Change from 2014-2021
8.4 Latin America Immuno Oncology Therapy Import and Export from 2014-2021
8.5 Latin America Immuno Oncology Therapy Market Value ($) and Growth (%) by Type from 2014-2021
8.6 Latin America Immuno Oncology Therapy Market Value ($) and Growth (%) by Application from 2014-2021
8.7 Latin America Immuno Oncology Therapy Market Value ($) and Growth (%) by Countries from 2014-2021
8.7.1 Brazil
8.7.2 Mexico
8.7.3 Argentina
8.7.4 Chile
8.7.5 Colombia
…
8.8 Top Latin America Immuno Oncology Therapy Participants Value ($) and Market Share (%) in 2020
9 Middle East & Africa Immuno Oncology Therapy Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
9.1 Middle East & Africa Immuno Oncology Therapy Value ($) from 2014-2021
9.2 Middle East & Africa Immuno Oncology Therapy Market Size from 2014-2021
9.3 Middle East & Africa Immuno Oncology Therapy Price Change from 2014-2021
9.4 Middle East & Africa Immuno Oncology Therapy Import and Export from 2014-2021
9.5 Middle East & Africa Immuno Oncology Therapy Market Value ($) and Growth (%) by Type from 2014-2021
9.6 Middle East & Africa Immuno Oncology Therapy Market Value ($) and Growth (%) by Application from 2014-2021
9.7 Middle East & Africa Immuno Oncology Therapy Market Value ($) and Growth (%) by Countries from 2014-2021
9.7.1 Egypt
9.7.2 Saudi Arabia
9.7.3 United Arab Emirates
9.7.4 Nigeria
9.7.5 South Africa
…
9.8 Top Middle East & Africa Immuno Oncology Therapy Participants Value ($) and Market Share (%) in 2020
10. Global Level Competitive Intelligence – Company Profiles
10.1 Amgen
10.1.1 Amgen Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.1.2 Amgen Sales, Value, Gross and Gross Margin from 2014-2021
10.1.3 Amgen Value and Growth Change from 2014-2021
10.1.4 Amgen Price Change from 2014-2021
10.1.5 Amgen Product Offered
10.2 AstraZeneca
10.2.1 AstraZeneca Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.2.2 AstraZeneca Sales, Value, Gross and Gross Margin from 2014-2021
10.2.3 AstraZeneca Value and Growth Change from 2014-2021
10.2.4 AstraZeneca Price Change from 2014-2021
10.2.5 AstraZeneca Product Offered
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.3.2 Bristol-Myers Squibb Sales, Value, Gross and Gross Margin from 2014-2021
10.3.3 Bristol-Myers Squibb Value and Growth Change from 2014-2021
10.3.4 Bristol-Myers Squibb Price Change from 2014-2021
10.3.5 Bristol-Myers Squibb Product Offered
10.4 Eli-Lilly
10.4.1 Eli-Lilly Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.4.2 Eli-Lilly Sales, Value, Gross and Gross Margin from 2014-2021
10.4.3 Eli-Lilly Value and Growth Change from 2014-2021
10.4.4 Eli-Lilly Price Change from 2014-2021
10.4.5 Eli-Lilly Product Offered
10.5 Roche
10.5.1 Roche Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.5.2 Roche Sales, Value, Gross and Gross Margin from 2014-2021
10.5.3 Roche Value and Growth Change from 2014-2021
10.5.4 Roche Price Change from 2014-2021
10.5.5 Roche Product Offered
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.6.2 GlaxoSmithKline Sales, Value, Gross and Gross Margin from 2014-2021
10.6.3 GlaxoSmithKline Value and Growth Change from 2014-2021
10.6.4 GlaxoSmithKline Price Change from 2014-2021
10.6.5 GlaxoSmithKline Product Offered
10.7 Janssen Biotech
10.7.1 Janssen Biotech Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.7.2 Janssen Biotech Sales, Value, Gross and Gross Margin from 2014-2021
10.7.3 Janssen Biotech Value and Growth Change from 2014-2021
10.7.4 Janssen Biotech Price Change from 2014-2021
10.7.5 Janssen Biotech Product Offered
10.8 Merck
10.8.1 Merck Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.8.2 Merck Sales, Value, Gross and Gross Margin from 2014-2021
10.8.3 Merck Value and Growth Change from 2014-2021
10.8.4 Merck Price Change from 2014-2021
10.8.5 Merck Product Offered
10.9 Novartis
10.9.1 Novartis Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.9.2 Novartis Sales, Value, Gross and Gross Margin from 2014-2021
10.9.3 Novartis Value and Growth Change from 2014-2021
10.9.4 Novartis Price Change from 2014-2021
10.9.5 Novartis Product Offered
10.10 Pfizer
10.10.1 Pfizer Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.10.2 Pfizer Sales, Value, Gross and Gross Margin from 2014-2021
10.10.3 Pfizer Value and Growth Change from 2014-2021
10.10.4 Pfizer Price Change from 2014-2021
10.10.5 Pfizer Product Offered
10.11 Sanofi
10.11.1 Sanofi Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.11.2 Sanofi Sales, Value, Gross and Gross Margin from 2014-2021
10.11.3 Sanofi Value and Growth Change from 2014-2021
10.11.4 Sanofi Price Change from 2014-2021
10.11.5 Sanofi Product Offered
10.12 Spectrum Pharmaceuticals
10.12.1 Spectrum Pharmaceuticals Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.12.2 Spectrum Pharmaceuticals Sales, Value, Gross and Gross Margin from 2014-2021
10.12.3 Spectrum Pharmaceuticals Value and Growth Change from 2014-2021
10.12.4 Spectrum Pharmaceuticals Price Change from 2014-2021
10.12.5 Spectrum Pharmaceuticals Product Offered
10.13 Takeda
10.13.1 Takeda Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.13.2 Takeda Sales, Value, Gross and Gross Margin from 2014-2021
10.13.3 Takeda Value and Growth Change from 2014-2021
10.13.4 Takeda Price Change from 2014-2021
10.13.5 Takeda Product Offered
10.14 BioNTech SE
10.14.1 BioNTech SE Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.14.2 BioNTech SE Sales, Value, Gross and Gross Margin from 2014-2021
10.14.3 BioNTech SE Value and Growth Change from 2014-2021
10.14.4 BioNTech SE Price Change from 2014-2021
10.14.5 BioNTech SE Product Offered
10.15 Allogene Therapeutics
10.15.1 Allogene Therapeutics Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.15.2 Allogene Therapeutics Sales, Value, Gross and Gross Margin from 2014-2021
10.15.3 Allogene Therapeutics Value and Growth Change from 2014-2021
10.15.4 Allogene Therapeutics Price Change from 2014-2021
10.15.5 Allogene Therapeutics Product Offered
10.16 IMAB-I-Mab Biopharma Co., Ltd.
10.16.1 IMAB-I-Mab Biopharma Co., Ltd. Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.16.2 IMAB-I-Mab Biopharma Co., Ltd. Sales, Value, Gross and Gross Margin from 2014-2021
10.16.3 IMAB-I-Mab Biopharma Co., Ltd. Value and Growth Change from 2014-2021
10.16.4 IMAB-I-Mab Biopharma Co., Ltd. Price Change from 2014-2021
10.16.5 IMAB-I-Mab Biopharma Co., Ltd. Product Offered
10.17 Arcus Biosciences
10.17.1 Arcus Biosciences Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.17.2 Arcus Biosciences Sales, Value, Gross and Gross Margin from 2014-2021
10.17.3 Arcus Biosciences Value and Growth Change from 2014-2021
10.17.4 Arcus Biosciences Price Change from 2014-2021
10.17.5 Arcus Biosciences Product Offered
10.18 Gritstone Oncology
10.18.1 Gritstone Oncology Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.18.2 Gritstone Oncology Sales, Value, Gross and Gross Margin from 2014-2021
10.18.3 Gritstone Oncology Value and Growth Change from 2014-2021
10.18.4 Gritstone Oncology Price Change from 2014-2021
10.18.5 Gritstone Oncology Product Offered
10.19 Autolus Therapeutics
10.19.1 Autolus Therapeutics Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.19.2 Autolus Therapeutics Sales, Value, Gross and Gross Margin from 2014-2021
10.19.3 Autolus Therapeutics Value and Growth Change from 2014-2021
10.19.4 Autolus Therapeutics Price Change from 2014-2021
10.19.5 Autolus Therapeutics Product Offered
10.20 Rubius Therapeutics
10.20.1 Rubius Therapeutics Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.20.2 Rubius Therapeutics Sales, Value, Gross and Gross Margin from 2014-2021
10.20.3 Rubius Therapeutics Value and Growth Change from 2014-2021
10.20.4 Rubius Therapeutics Price Change from 2014-2021
10.20.5 Rubius Therapeutics Product Offered
11. Market Dynamics
11.1 Driving Factors
11.1.1 Rising Demand in Some Regions: North America/Europe/China/India/Japan …
11.1.2 Increasing Use of Immuno Oncology Therapy by Different End-User/Applications
11.2 Restraints and Challenges in the Market
11.3 Opportunities
11.4 Covid-19 Impact/Evaluation
12. Future Forecast of Global Immuno Oncology Therapy Market from 2020-2026
12.1 Future Forecast of Global Immuno Oncology Therapy Market from 2020-2026 Segment by Regions
12.2 Future Forecast of Global Immuno Oncology Therapy Market from 2020-2026 Segment by Type
12.3 Future Forecast of Global Immuno Oncology Therapy Market from 2020-2026 Segment by Application
13. Investment Analysis
13.1 Fundamental Analysis (Porter's Five Forces Analysis)
13.2 Technical Preparation Analysis
13.3 Risk Evaluating Analysis
13.4 Estimated Investment Pay-Back Period
14 Research Methodology
14.1 Research Data
14.1.1 Secondary Data
14.1.2 Primary Data
14.2 Revenue Estimation
14.2.1 Bottom-Up Approach
14.2.2 Top-Down Approach (Involves time, Space, and Persons)
14.3 Data Triangulation
14.4 Assumptions
14.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
14.6 Limitations of Our Study
14.7 Scene Based Modeling
15 Disclaimer
Research Methodology:
Immuno Oncology Therapy Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|